IRadimed Corporation (IRMD)
| Bid | 49.71 |
| Market Cap | 673.9M |
| Revenue (ttm) | 73.24M |
| Net Income (ttm) | 19.23M |
| EPS (ttm) | 1.5 |
| PE Ratio (ttm) | 35.33 |
| Forward PE | 26.1 |
| Analyst | Strong Buy |
| Ask | 58.12 |
| Volume | 27,498 |
| Avg. Volume (20D) | 39,770 |
| Open | 52.48 |
| Previous Close | 52.41 |
| Day's Range | 52.18 - 53.84 |
| 52-Week Range | 41.60 - 63.29 |
| Beta | 0.83 |
About IRMD
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also provides non-magnetic IV poles, wireless remote dis...
Analyst Forecast
According to 1 analyst ratings, the average rating for IRMD stock is "Strong Buy." The 12-month stock price forecast is $72, which is an increase of 35.85% from the latest price.
Stock ForecastsNext Earnings Release
Analysts project revenue of ... Unlock content with Pro Subscription
3 weeks ago · seekingalpha.com
IRadimed Corporation: Steady, Low-Risk Grower In The Devices SpaceIRadimed Corporation offers steady revenue growth with 14 consecutive quarters of record revenue and a small dividend, despite recent stock price decline. IRMD's unique MRI-compatible IV infusion pump...
